|
|
|
| home > epc > current issue |
|
|
 PUBLICATIONS |
|
|
 |
News and Press Releases |
 |
NDA Group Releases Data Comparing FDA and EMA Ahead of Annual DIA Europe in Basel
Today NDA Group announced their findings from its fifth annual
comparison of drug approvals in Europe and the United States, in
preparation for this year’s DIA Europe in Basel, Switzerland. The
figures highlight the continued differences between the two regions, and
the need for a global approach to drug development to ensure success
across both continents.
More info >> |
|
 |
White Papers |
 |
|
Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery
Presspart Manufacturing Ltd
Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >> |
|
 |
Industry Events |
 |
Cell Line Development and Engineering
23-25 April 2018, RAI, Amsterdam
Cell Line
Development & Engineering 2018 event will be held 23-25
April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in
Europe – BPI Europe.
More info >> |
|
|
